Nisnisan, Jennilyn O.
HRN: 18-94-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2024
CEFUROXIME 1.5GM (VIAL)
08/17/2024
08/17/2024
IV
1.5g
1
Prophylaxis For CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes